SPRAY-CB: A Sham controlled prospective randomized trial of the RejuvenAir system for the treatment of moderate to severe chronic obstructive pulmonary disease with chronic bronchitis
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
CSA Medical, Inc.
Start Date
April 13, 2020
End Date
July 31, 2025
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
CSA Medical, Inc.
Start Date
April 13, 2020
End Date
July 31, 2025